Literature DB >> 25254605

Network analysis in the investigation of chronic respiratory diseases. From basics to application.

Diego Diez1, Alvar Agustí, Craig E Wheelock.   

Abstract

Chronic respiratory diseases are complex multifactorial disorders whose pathogenesis depends on the interplay between host and environmental factors. To fully understand them and to identify novel treatments, a holistic approach that integrates multiple types and levels of clinical and biological data is necessary. Toward this end, the application of systems biology-based strategies, in particular, network analysis, offers great potential. These systems-based approaches rely heavily on computational methods that can be challenging for the nonspecialist. Accordingly, this Pulmonary Perspective: (1) outlines the basic concepts of networks in biology and the fundamentals of network analysis, and (2) discusses recent applications of network analysis to understand respiratory diseases. The intent of this Perspective is to provide readers with increased understanding of the strengths and weaknesses of network analysis methods as well as their usefulness in addressing research questions involving chronic respiratory diseases.

Entities:  

Keywords:  gene regulatory network; protein–protein interaction network; signaling network; systems biology; systems medicine

Mesh:

Year:  2014        PMID: 25254605     DOI: 10.1164/rccm.201403-0421PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  20 in total

1.  Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.

Authors:  Alvar Agustí; Josep Maria Antó; Charles Auffray; Ferran Barbé; Esther Barreiro; Jordi Dorca; Joan Escarrabill; Rosa Faner; Laura I Furlong; Judith Garcia-Aymerich; Joaquim Gea; Bertil Lindmark; Eduard Monsó; Vicente Plaza; Milo A Puhan; Josep Roca; Juan Ruiz-Manzano; Laura Sampietro-Colom; Ferran Sanz; Luis Serrano; James Sharpe; Oriol Sibila; Edwin K Silverman; Peter J Sterk; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

Review 2.  Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.

Authors:  Prescott G Woodruff; Alvar Agusti; Nicolas Roche; Dave Singh; Fernando J Martinez
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

3.  Drug development for airway diseases: looking forward.

Authors:  Stephen Holgate; Alvar Agusti; Robert M Strieter; Gary P Anderson; Robert Fogel; Elisabeth Bel; Thomas R Martin; Theodore F Reiss
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

4.  LSC 2016: from system approaches in lung disease to getting the job you want.

Authors:  Agnes Boots; Emma Flood; Nicolas Kahn; Georgia Hardavella; Andras Bikov; Ane Aamli; Szymon Skoczynski
Journal:  Breathe (Sheff)       Date:  2016-06

5.  Prioritizing chronic obstructive pulmonary disease (COPD) candidate genes in COPD-related networks.

Authors:  Yihua Zhang; Wan Li; Yuyan Feng; Shanshan Guo; Xilei Zhao; Yahui Wang; Yuehan He; Weiming He; Lina Chen
Journal:  Oncotarget       Date:  2017-10-17

6.  Chronic obstructive pulmonary disease candidate gene prioritization based on metabolic networks and functional information.

Authors:  Xinyan Wang; Wan Li; Yihua Zhang; Yuyan Feng; Xilei Zhao; Yuehan He; Jun Zhang; Lina Chen
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

7.  Network modules uncover mechanisms of skeletal muscle dysfunction in COPD patients.

Authors:  Ákos Tényi; Isaac Cano; Francesco Marabita; Narsis Kiani; Susana G Kalko; Esther Barreiro; Pedro de Atauri; Marta Cascante; David Gomez-Cabrero; Josep Roca
Journal:  J Transl Med       Date:  2018-02-20       Impact factor: 5.531

8.  Network science meets respiratory medicine for OSAS phenotyping and severity prediction.

Authors:  Stefan Mihaicuta; Mihai Udrescu; Alexandru Topirceanu; Lucretia Udrescu
Journal:  PeerJ       Date:  2017-05-09       Impact factor: 2.984

9.  The EASI model: A first integrative computational approximation to the natural history of COPD.

Authors:  Alvar Agustí; Albert Compte; Rosa Faner; Judith Garcia-Aymerich; Guillaume Noell; Borja G Cosio; Robert Rodriguez-Roisin; Bartolomé Celli; Josep Maria Anto
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

10.  Towards a global initiative for fibrosis treatment (GIFT).

Authors:  Maria Molina-Molina; Alvar Agusti; Bruno Crestani; David A Schwartz; Melanie Königshoff; Rachel C Chambers; Toby M Maher; Rosa Faner; Ana Lucia Mora; Mauricio Rojas; Katerina M Antoniou; Jacobo Sellares
Journal:  ERJ Open Res       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.